SEER
Seer, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.95
+0.52%Aug 11, 2026, 20:05 UTC
Seer, Inc. announced its financial results for the second quarter ended June 30, 2026.
Jul 28, 2026, 16:47 UTC
Bradley L. Radoff and Michael Torok, owning about 7.7% of Seer, Inc., submitted a non-binding proposal to acquire Seer for $2.55 per share in cash plus a contingent value right.
Jul 6, 2026, 10:50 UTC
Seer's CEO submitted a buyout proposal for the company.
Source:Jul 2, 2026, 21:00 UTC
Seer, Inc. received an unsolicited acquisition proposal from Omid Farokhzad, M.D.
Source: